ALVigiLance is a dedicated pharmacovigilance platform designed to support the healthcare team in ensuring safer medication use. Our mission is simple yet vital: to provide trusted insights, practical tools, and up-to-date resources that empower healthcare professionals to identify, prevent, and manage adverse drug reactions (ADRs).
Simplified, practical guides on drug safety and monitoring.
Real-world examples to strengthen your clinical decision-making.
Summaries of global drug warnings and regulatory actions.
Strategies for adverse event reporting, risk management, and patient counseling.
To create a proactive community of healthcare providers who champion medication safety and improve patient outcomes through shared knowledge and vigilance.
Medication safety is everyone’s responsibility. Explore, learn, and engage with ALVigiLance — because together, we can reduce risks and save lives.
Product information updates for desogestrel/etonogestrel and meningioma, levonorgestrel intrauterine systems and ectopic pregnancy, and information concerning atogepant and insomnia, CGRP antagonists and Raynaud's phenomenon, oseltamivir safety...
The digital revolution—encompassing AI, machine learning, big data analytics, EHRs, mobile applications, and social media monitoring—is reshaping how ADRs are detected, assessed, and prevented.
This essay provides a comprehensive examination of RCA methodologies within, exploring the application of Six Sigma and DMAIC frameworks, the A3 problem-solving approach, and the essential...
